Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse™ ICD
23 September 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for one of Abbott's most widely-used implantable cardioverter defibrillators (